ArticleFrontiers in microbiology2019
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 23 citations in OpenAlex.
- Growth inhibition ofMicrobiology spectrum · 2025Article
- A decade of genomic and phenotypic adaptation of carbapenem-resistantFrontiers in cellular and infection microbiology · 2025Article
- Article
- Identification and functional characterization of a novelFrontiers in cellular and infection microbiology · 2025Article
- Genomic characterization of multidrug-resistant clinicalFrontiers in cellular and infection microbiology · 2025Article
- Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer AgainstAntibiotics (Basel, Switzerland) · 2024Article
- Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40International journal of molecular sciences · 2024Article
- First report on in-depth genome and comparative genome analysis of a metal-resistant bacteriumFrontiers in microbiology · 2024Article
- Genome sequences ofMicrobiology resource announcements · 2023Article
- Phylogenomics ofFrontiers in microbiology · 2023Article
- Metagenomic Insights into Pathogenic Characterization of ST410Pathogens (Basel, Switzerland) · 2022Article
- Prophages Present inPHAGE (New Rochelle, N.Y.) · 2022Article
- Emergence of uncommon KL38-OCL6-ST220 carbapenem-resistantFrontiers in cellular and infection microbiology · 2022Article
- Surgical Site Infection Following Caesarean Section byMicroorganisms · 2021Article
- Genomic Characterization of Clinical Extensively Drug-ResistantMicroorganisms · 2021Article
- Summary of Novel Bacterial Isolates Derived from Human Clinical Specimens and Nomenclature Revisions Published in 2018 and 2019.Journal of clinical microbiology · 2021Review
- Emergence of ST63 Pandrug-ResistantFrontiers in cellular and infection microbiology · 2021Article
- Modulation of Quorum Sensing and Biofilms in Less Investigated Gram-Negative ESKAPE Pathogens.Frontiers in microbiology · 2021Review
- Photoelimination Potential of Chitosan Nanoparticles-Indocyanine Green Complex Against the Biological Activities ofJournal of lasers in medical sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increased use of molecular identification methods and mass spectrometry has revealed that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.